PARTNERSHIPS IN THE PRACTICE
Wednesday, February 9, 15:30 - 17:00
About Liana Steeghs | Director Alliance Management
Liana Steeghs has over twenty-five years’ experience in the Life Sciences sector. She joined Genmab in October 2018 as Alliance Manager being responsible for Genmab’s portfolio of alliances with European biotech and pharma companies. Previously, she held positions as Program Manager, Deputy Director and Managing Director at Immuno Valley, a non-profit organization establishing public-private R&D partnerships between global pharma companies, biotech and academic institutions in the field of infectious diseases. Liana holds a PhD degree in Molecular Microbiology from the University of Utrecht (NL) and has worked as principal investigator in immune mechanism research and vaccine development at public institutions in the Netherlands and the UK.
About Genmab
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company is the creator of the following approved antibodies: DARZALEX®, Arzerra, TEPEZZA®, Kesimpta® and DARZALEX FASPRO™. Genmab also has a broad clinical and pre-clinical product pipeline. Genmab's technology base consists of validated and proprietary next generation antibody technologies such as the DuoBody®, HexaBody® and the HexElect® platform. Genmab has alliances with top tier pharmaceutical and biotechnology companies and is headquartered in Copenhagen, Denmark with sites in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.
| Powered by: BCF Courses BV | Connect with us | Join BioBusiness Winter School | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 75874415 | | Register |
| © Copyright 2021 by BCF Courses |